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well-being in active seniors but not in patients
with subjective memory complaints
Lovisa A Olsson1,2*, Nils-Olof Hagnelius3 and Torbjörn K Nilsson4Abstract
Background: During our whole life span, factors influencing health and functioning are accumulated. In chronic
kidney disease, quality of life is adversely affected. We hypothesized that biomarkers of renal function could also be
determinants of subjective well-being (SWB) in Swedish elderly subjects. SWB was assessed by the Psychological
General Well-Being index (PGWB index) in two study groups: Active seniors (AS) consisted of community-dwelling
elderly Swedes leading an active life (n = 389), and the DGM cohort (n = 300) consisted of subjects referred to the
Memory Unit at the Department of Geriatrics for memory problems, Serum creatinine, cystatin C, and eGFR (CKD-EPI)
were used as biomarkers of renal function.
Results: There were no significant differences in cystatin C and eGFR values between the two cohorts: cystatin C
medians 0.88 vs 0.86 mg/L and eGFR 73 vs 80 mL/min/1.73 m2 (AS vs DGM). In the AS cohort cystatin C was negatively
related to PGWB index in women (P < 0.001, R2≈ 5%), and the covariates age and BMI did not improve the models.
The renal biomarkers were unrelated to the PGWB index in the DGM cohort. Cystatin C in the AS cohort was adversely
related to the PGWB subdimensions anxiety, depressed mood, positive well-being, and vitality in women, but in men
only to depressed mood (P < 0.006; R2≈ 6%). In the DGM cohort, depressed mood in men was also significantly related
to cystatin C (P = 0.050), but not in women.
Conclusions: Renal function even within the normal range, measured by serum cystatin C concentration, has
significant and sex specific associations with subjective well-being and its subdimensions in healthy elderly subjects.
Maintenance of good renal function in aging may be of importance in maintaining a high subjective well-being.
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During our whole life span, factors that influence health
and functioning are accumulated; these factors include
genetics, environment, and individual life experience and
exposures [1]. Moderate renal dysfunction is increasing
worldwide [2] and has been associated with an increased
risk of death from cardiovascular events and kidney
failure [3-5] and a number of other clinical conditions
[6,7]. While it is well known that in more pronounced
renal dysfunction (chronic kidney disease, CKD), quality* Correspondence: lovisa.olsson@orebroll.se
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unless otherwise stated.of life (QoL) is adversely affected [8-10] there is a relative
dearth of studies addressing the possibility that CKD
could also be related to Subjective Well-Being (SWB), a
person’s own evaluation of his or her life. Such evaluations
may be judgments about the person’s life as a whole or
evaluations of specific dimensions of life, both positive
and negative [1,11]. In particular, next to nothing is known
about the possibility that SWB (or QoL) might be affected
even by moderate renal dysfunction (MRD), perhaps
even while biomarkers of renal function, used to esti-
mate glomerular filtration (eGFR), still remain within
the reference interval.
S-creatinine and S-cystatin C are commonly used as
biomarkers to calculate eGFR. Among the disadvantages
of C-creatinine as a GRF marker are its dependence on
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Figure 1 Cystatin C values in in the two study groups stratified
by age in 5-year intervals. Mean values and 95% CIs of the means
are shown. The dotted lines show our in-house reference values for
the 51-65 year-olds (95% CI), and the continuous lines those of the
65-80 year-olds.
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protease inhibitor produced in nearly all human cells. Its
serum concentration is independent of muscle mass and
sex [12], and it has been proposed as a better biomarker of
GFR than creatinine [15].
We hypothesized that a possible negative effect of
kidney function on SWB could contribute substantially
to the total variance in SWB in an elderly population
even in the absence of CKD. The aim of this study was
thus to look for possible associations between established
biomarkers of renal function (S-creatinine, S-cystatin C,




Active Seniors (AS) cohort was recruited during 2003 and
2004 by a multi-phase sampling procedure aimed at an
elderly retired population living in various communities in
Central Sweden. The locations for the recruitment were
selected to represent a broad range of socioeconomic
levels and included rural as well as urban and suburban
areas. The sample consisted of 389 senior citizens and
was recruited from several retired persons’ organisations,
which implicates that they are independent and socially
active. Being retired, living independently in their own
homes in addition to participation in such organisations
were the sole inclusion criteria, not pre-set health criteria.
We have designated them as ‘Active Seniors’ in contrast to
elderly persons that do not engage themselves in such
social activity. All were Caucasians, most of them born in
the 1920’s and 1930’s, mean age at sampling was 74 ±
5 years for both sexes and the sex ratio M/F was 127/262.
Based upon the cystatin C values in different age groups
(Figure 1), the number of AS subjects with cystatin C
above the upper reference limit (1.55 mg/L) was 7 women
and 3 men (total prevalence 2.6%).
A random subset of the AS cohort was assessed by the
Mini Mental State Examination (MMSE) [16] and the
clock drawing test (CDT) judged according to Shulman
[17]. These subjects (n = 154) were found to be cogni-
tively intact, defined as MMSE ≥ 28 and CDT ≥ 4 Neither
the PGWB score nor any of the studied biomarkers
differed significantly between this subgroup and the
rest of the AS study group. We therefore regard the AS
cohort as a cognitively intact group of elderly subjects.
Senior subjects with subjective or objective cognitive
complaints (DGM cohort) were recruited from an incident
case study at the University Hospital, Örebro Sweden [18].
Briefly this study population consisted of 300 consecutive
patients (143 men and 157 women) who were referred
to the Memory Unit at the Department of Geriatrics
for diagnostic assessment and treatment of suspected
cognitive problems. The inclusion period extended fromMay 2003 to August 2007. The cognitive problems had
to be mild or moderate, defined as MMSE score ≥10;
according to current Swedish research ethics legislation
it is unethical and thus forbidden to include subjects with
more severe dementia due to their reduced autonomy.
Dementia diagnoses were based on DSM-IV criteria
ICD-10 criteria was used to divide dementia patients
into different diagnostic categories. Mixed dementia
(F 00.2 according to ICD-10) was diagnosed in cases of
coexistence of AD and a history of vascular risk factors
e.g. transitory ischemic attack(s). atrial fibrillation, hyper-
tension, diabetes mellitus, Hachinski ischemic score ≥ 6
and CT scan showing ischemic changes. Probable AD was
diagnosed in accordance with the NINCDS-ADRDA
criteria. Of the 73 subjects classified as ND, 39 were
MCI. Everyone in the study group completed the PGWB
questionnaire without assistance during their visit at the
Memory unit. Based upon the cystatin C values in different
age groups (Figure 1), the number of DGM subjects with
cystatin C above the upper reference limit (1.55 mg/L) was
12 women and 9 men (total prevalence 7%).
All subjects gave a specific and written informed consent
to the present study including genotyping and biobanking
of the donated samples. The Research Ethics Committee of
Örebro County Council and the Regional Ethics Review
Board (Uppsala) approved the study. Height and weight
(SECA digital scale, 99% of the subjects) were measured
and BMI (kg/m2) was calculated. The resting systolic and
diastolic blood pressure was measured using an automatic
oscillometric method (Dinamap model XL Critikron, Inc.,
Tampa, Florida.). The equipment has been validated.
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The Psychological General Well-Being (PGWB) index,
accessible from MAPI Research institute, www.mapi-
trust.fr, was used to measure subjective well-being or
distress [19]. It consists of 22 items that reflect a sense
of subjective well-being and distress during the past
week. The items are divided into six dimensions, anxiety,
depressed mood, positive well-being, self-control, general
health, and vitality; these are also combined to a global
overall score of SWB. Response categories for all items
were simplified to a 6-point Likert scale. A high value
indicates a high level of well-being. In order to achieve this
interpretation of the score-points even for the dimensions
which reflect distress (depressed mood and anxiety).
score-points for these items were assigned in the direction
of “6” to “1” in contrast to the usual direction of “1” to “6”.
The overall sum of scores gives a maximum value of 132
(best SWB) and a minimum of 22 (poorest SWB).
Blood sampling and biochemical measurements
Blood samples were taken with the subjects in the supine
position, by venipuncture using vacuum tubes with gel,
Becton Dickison. Serum was obtained after clotting for 30
to 60 minutes at room temperature and centrifuging at
room temperature for 10 minutes at 2000 g. All samples
were stored at -80°C. The serum samples were analysed
on a Hitachi 911 multianalyser, Roche, Mannheim, FRG.
Creatinine was analysed using a enzymatic method, Crea
plus, from Roche/Boehringer Mannheim FRG, and the
calibrator was IDMS standardised. Albumin, IgG, IgA and
IgM were analysed by immunoturbidimetry using reagents
from DAKO, Copenhagen, Denmark and cystatin C by
immunoparticle turbidimetry from Gentian AS, Moss,
Norway. LDL and HDL cholesterol were measured by
direct, homogeneous assays based on detergent treat-
ment of the serum. N-geneous™ HDL-c and N-geneous™
LDL reagents, respectively, from Genzyme Corporation,
Cambridge, MA, USA.
Estimated glomerular filtration rate (eGFR) was calcu-
lated using the equation which include both creatinine and
cystatin C from the Chronic Kidney Disease Epidemiology
collaboration. This equation includes both creatinine and
cystatin C as well as age, sex and race [20]. In the present
study all participants were of European descent.
Statistics
All variables were checked for normality of distribution
and collinearity before analysis. Continuous variables with
a skewed distribution were transformed using natural
logarithms before regression analyses were made. The
Mann-Whitney rank sum test was used to compare the
PGWB sum and PGWB sub-dimension between gender
in the two cohorts, median and interquartile range for
descriptive statistics of these variables.A forward multiple regression was used to determine the
degree to which variance in PGWB index was explained by
age, BMI, gender and, cystatin C or creatinin. To examine
which of the subdimensions contributed to the variance in
PGWB index ANCOVA analyses were done with age,
BMI, and biomarkers of kidney function as covariates.
All multivariate regression models were performed after
stratification, since we have found profound differences
between SWB in the AS and DGM cohorts [21].
Statistical analyses were performed using SPSS version
15.0 (Chicago, Illinois, USA), and PGWB Statistical signifi-
cance were considered with a probability value <0.05.
In the AS study group, 4 subjects failed to complete
the PGWB questionnaire and responses from 12 subjects
failed to answer one or two questions randomly distrib-
uted among the 22 questions. The missing answers were
imputed using the manual from MAPI research institute.
Results
Baseline characteristics
Baseline characteristics of the two study groups are shown
in Table 1. Men in the DGM cohort were significantly
younger than in the AS cohort. Within the AS cohort
men had significantly higher diastolic blood pressure and
serum creatinine concentrations than women. Within
the DGM cohort creatinine and plasma IgA differed
significantly between sexes. Serum creatinine mean con-
centrations also differed between women in the AS and
DGM cohorts, while there was no difference between
any sub-group comparison concerning cystatin C mean
concentrations. There was a difference in eGFR between
the two study groups, and also between the sexes in the
AS cohort, but the prevalence of subjects with an eGFR
(KDGIO) < 60 mL/min/1.73 m2 was similar, 22%, in
both the AS and DGM cohorts. A cystatin C concentra-
tion >1.1 mg/mL was found in 16% of subjects in the
AS cohort and 22% in the DGM cohort.
There were group differences in SWB, assessed by the
PGWB instrument, between the two cohorts, see Table 2.
In the DGM cohort men had significantly higher well-being
than women in all sub-dimensions but positive well-being.
In the AS cohort the only sex difference was that women
had a significantly lower degree of self-control. When
comparing women in the AS and the DGM cohorts,
DGM women had significantly lower SWB than AS
women. That was also the finding comparing men in both
cohorts, except for general health.
Biomarkers of renal function and PGWB index
In the AS cohort, cystatin C was significantly and nega-
tively related to PGWB index in women, explaining ≈ 5%
of the variance in SWB, as seen in Table 3. Addition of the
covariates age and BMI did not substantially improve this
model. In men too there was a negative correlation of
Table 1 Baseline and laboratory characteristics of the studied 689 seniors
Mean (SD) and p-values for
the sex differences are shown
Active seniors cohort DGM cohort
Women n = 262 Men n = 127 Pa Women n = 157 Men n = 143 Pa Pb Pc
Age. yr 74.4 (7.2) 75.0 (6.4) NS 73.3 (10.6) 72.5 (9.5) NS NS 0.028
Height, cm 163 (5.8) 177 (6.7) <0.001 163 (5.9) 176 (1.2) <0.001 <0.001 <0.001
BMI, kg/cm2 26.0 (4.2) 26.1 (3.5) NS 25.8 (3.7) 26.2 (3.7) NS NS NS
systBPsitting, mm Hg 148.9 (26.1) 146 (22.5) NS 150 (23.7) 149 (23.6) NS NS NS
diastBPsitting, mm Hg 76.3 (11.3) 78.0 (10.4) 0.013 82.3 (12.5) 84.1 (12.1) NS <0.001 <0.001
S-Creatinine, umol/L 87.4 (21.5) 101 (16.8) <0.001 78.9 (36.6) 97.9 (58.9) <.001 <0.001 NS
S-Cystatin C, mg/L 1.02 (0.25) 1.04 (0.22) NS 0.98 (0.54) 1.01 (0.45) NS NS NS
eGFR mL/min/1,73 m2 70.1 (15.95) 74.0 (14.48) 0.022 76.1 (22.8) 78.6 (23.24) NS 0.002 0.049
hS-CRP, mg/L 2.06 (2.13) 2.90 (3.74) NS 3.34 (6.38) 5.51 (16.01) NS NS NS
P-Albumin, g/L 40.9 (3.41) 40.7 (3.46) NS 36.5 (3.30) 36.9 (3.22) NS <0.001 <0.001
P-IgG, g/L 11.9 (2.7) 12.1 (2.9) NS 9.83 (2.38) 10.24 (2.69) NS <0.001 <0.001
P-IgM, g/L 1.23 (0.79) 1.09 (1.50) NS 1.01 (0.99) 0.86 (0.62) NS 0.035 NS
P-IgA, g/L 2.37 (.08) 1.40 (0.36) 0.004 2.16 (1.21) 2.62 (1.07) 0.002 NS NS
eGFR = CKD-EPI creatinin-cystatin C equation [20].
Pa Sex difference within cohort.
Pb Difference between women in the AS and DGM cohorts.
Pc Difference between men in the AS and DGM cohorts.
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ically similar to the one in women (-10.1 vs. -12.2), and
reached borderline statistical significance (P = 0.06). Just
as in women, addition of age and BMI as covariates did
not change this pattern; cystatin C retained its β value
around the same numerical level (-10.7), again showing
borderline significance (P = 0.07).
In the AS cohort, serum creatinine too was, in women,
significantly and negatively related to PGWB index
(P = 0.02) but explained only ≈ 2% of its variance. Adding
the covariates age and BMI increased the explanatory
power of the model to ≈ 6%. In men, creatinine was
unrelated to PGWB index, and adding age and BMI as
covariates did not improve the insignificant R2 (Table 3,
models 4 and 5).Table 2 SWB as PGWBsum and its subdimensions in the stud
Active seniors cohort
Women Men Pa
Anxiety 27 (24-29) 27 (25-29) Ns
Depressed mood 17 (15-18) 17 (15-18) NS
Pos.well-being 18 (15-19) 18 (16-19) NS
Self control 15 (16-17) 17 (16-17) 0.018
General. health 16 (14-17) 16 (13-17) NS
Vitality 19 (17-21) 19 (17-21) NS
PGWB sum 112 (101-118) 113 (105-118) NS
Pa Sex difference within cohort.
Pb Difference between women in the AS and DGM cohorts.
Pc Difference between men in the AS and DGM cohorts.
Median and the interquartile range 25% -75% are shown.In contrast, in the DGM cohort neither cystatin C nor
creatinine were significantly related to PGWB index, and
none of the extended models had any explanatory power
(Table 3, lower panel).
Cystatin C and PGWB subdimensions
In Table 4, the relations of PGWB subdimensions with
cystatin C are shown. In women in the AS cohort, cystatin
C was significantly and adversely related to the dimensions
anxiety, depressed mood, positive well-being, and vitality.
In contrast, in women in the DGM cohort cystatin C was
unrelated to any of the PGWB subdimension.
In men, in the AS cohort there was a significantly
adverse relation between cystatin C and depressed mood,
which explained ≈ 6% of its variance (P = 0.006). In they groups active seniors and DGM
DGM cohort
Women Men Pa Pb Pc
22 (20-27) 25 (22-28) 0.005 <0.001 <0.001
15 (13-17) 16 (14-17) 0.019 <0.001 <0.001
15 (12-18) 16 (13-18) Ns <0.001 <0.001
14 (12-16) 15 (13-16) 0.006 <0.001 <0.001
14 (12-13) 15 (13-17) 0.006 <0.001 NS
17 (13-20 18 (16-20) 0.016 <0.001 0.003
97.5 (85-109) 104 (90-115) 0.001 <0.001 <0.001







Model P R2model P R2model
1 cystatin C -12.2 <0.001 0.048 -10.1 0.061 0.019
2 Age -0.341 0.006 0.030 -0.013 0.942 -0.008
BMI 0.262 0.206 -0.315 0.345
3 Age -0.201 0.125 0.053 0.119 0.540 0.009
BMI -0.167 0.418 -0.150 0.662
cystatin C -9.721 0.008 -10.69 0.071
4 creatinine -10.359 0.017 0.019 -7.592 0.318 0.00
5 Age -0.283 0.029 0.058 0.020 0.915 -0.009
BMI -0.287 0.166 -0.281 0.406
creatinine -8.31 0.058 -8.255 0.288
4 eGFR 0.164 0.002 0.019 0.128 0.116 0.009
5 Age -0.203 0.157 0.038 0.160 0.455 0.003
BMI -0.198 0.341 -0.165 0.633






Model P R2model P R2model
1 Cystatin C 0.42 0.856 -0.006 -1.4 0.651 -0.006
2 Age 0.045 0.709 -0.009 0.136 0.366 -0.007
BMI 0.274 0.429 0.258 0.501
3 Age 0.045 0.728 -0.016 0.266 0.116 0.00
BMI 0.250 0.475 0.332 0.394
cystatin C 0.187 0.938 -3.699 0.289
4 creatinine 2.162 0.590 -0.005 2.943 0.526 -0.004
5 Age 0.035 0.774 -0.014 0.115 0.473 -0.013
BMI 0.271 0.434 0.261 0.498
creatinine 2.016 0.622 1.969 0.691
6 eGFR 0.021 0.698 -0.016 -0.016 0.787 0.000
7 Age 0.113 0.457 -0.012 0.279 0.173 -0.005
BMI 0.274 0.433 0,312 0.423
eGFR 0.050 0.462 0.053 0.514
Numbers in boldface indicate statistically significant associations.
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and adversely correlated with depressed mood (P = 0.050),
although the variance explained was minor (≈ 1%). In
the AS cohort, there was also an adverse relation
between positive well-being and cystatin C (P = 0.03),
explaining ≈ 2.5% of that subdimension.
Discussion
The main finding was a negative correlation between
SWB, assessed by the PGWB index and serum cystatin C
as a biomarker of renal function, even after adjusting
for age and BMI, in Active Seniors but not in subjects
with subjective memory complaints (DGM cohort), twocohorts of Swedish elderly subjects with a low prevalence
of chronic kidney disease (CKD) as judged from their
serum cystatin C concentrations.
There were marked gender differences in the adverse
relation between cystatin C and the subdimensions of
SWB. In women in the AS cohort all subdimensions
except self control were adversely related to cystatin C,
whereas in the DGM cohort cystatin C was unrelated
to any SWB subdimension. (see Table 4). In contrast, in
men, there was a significant adverse relation of cystatin
C only with depressed mood, and this relation was seen
both in the AS and in the DGM cohorts. Interestingly,
in the AS cohort the beta factor for men was twice that
Table 4 ANCOVA of the PGWB subdimensions
Women
Predictor variables
Active seniors cohort DGM cohort
PGWB subdimension β P R2model β P R2model
Anxiety Age -0.012 0.728 0.010 0.046 0.196 -0.003
BMI 0.019 0.730 0.071 0.462
cystatin C -1.955 0.046 0.265 0.692
Depressed mood Age -0.024 0.260 0.026 -0.029 0.183 0.001
BMI 0.002 0.948 0.055 0.353
Cystatin C -1.269 0.029 0.085 0.865
Positive well-being Age -0.039 0.191 0.031 -0.15 0.566 -0.003
BMI -0.001 0.975 0.089 0.205
Cystatin C -1.886 0.023 -0.162 0.738
Self control Age -0.024 0.259 0.018 0.012 0.604 -0.010
BMI -0.014 0.680 0.046 0.461
Cystatin C -1.019 0.078 0.303 0.83
General health Age -0.070 0.005 0.073 0.005 0.854 -0.015
BMI -0.078 0.043 -0.054 0.424
Cystatin C -1.021 0.133 0.037 0.938
Vitality Age -0.031 0.331 0.064 0.026 0.462 -0.015
BMI -0.093 0.063 0.043 0.652
Cystatin C -2.609 0.003 -0.339 0.606
Men
Predictor variables
Active seniors cohort DGM cohort
PGWB subdimension β P R2 β P R2
Anxiety Age -0.033 0.496 -0.015 0.069 0.122 -0.002
BMI 0.037 0.670 0.093 0.365
cystatin C -1.420 0.335 -0.567 0.537
Depressed mood Age -0.22 0.462 0.063 0.041 0.134 0.011
BMI -0.004 0.932 0.038 0.552
Cystatin C -2.472 0.006 -1.122 0.050
Positive well-being Age -0.014 0.728 0.025 0.025 0.478 -0.12
BMI 0.015 0.828 0.070 0.392
Cystatin C -2.649 0.031 0.154 0.833
Self control Age 0.072 0.009 0.032 0.060 0.032 0.032
BMI 0.027 0.572 0.073 0.256
Cystatin C -1.237 0.135 -0.944 0.103
General health Age 0.009 0.844 0.029 0.028 0.357 -0.006
BMI -0.145 0.059 -0.012 0.869
Cystatin C -1.654 0.209 -0.871 0.171
Vitality Age 0.034 0.480 -0.007 0.042 0.240 -0.009
BMI -0.050 0.554 0.069 0.398
Cystatin C -1.560 0.283 -0.349 0.635
Numbers in boldface indicate statistically significant associations.
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sensitivity to depressed mood in men, further supported
by the fact that this adverse relation was significant even
in males in the DGM cohort (beta value -1.1).To the best of our knowledge, the above findings
regarding the adverse relations between a biomarker of
renal function and important aspects of subjective well-
being in subjects with renal function within the normal
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about QoL have mostly been conducted in patients with
CKD, end state renal disease (ESRD), or on hemodialysis,
with QoL as outcome variable, not SWB. Health Related
Quality of Life (HRQoL) has been found to be reduced in
proportion to the severity of CKD [22,23]. Our findings
thus extend the scope of renal function twofold, both
to another dimension besides QoL, namely SWB, and
to the importance of minor reduction in renal function
as a determinant of SWB.
In the Health, Aging and Composition study, cystatin
C was not associated with depression at baseline but
participants having cystatin C higher than 1.25 mg/L had
an increased risk to develop diagnosed depression [24].
In the prospective Cardiovascular Health Study, cystatin
C was associated with depression among participants
without CKD at baseline but this was a borderline asso-
ciation after adjusting for both demographic and clinical
measures [25]. We regard these studies as consistent
with our finding of an adverse relation between cystatin
C and depressed mood in both sexes in the AS cohort,
and among men even in the DGM cohort.
SWB includes a person’s evaluation of his or hers life,
both positive and negative feelings as well as perceptions
of one’s situation. In our model cystatin C explained 6%
of the SWB variance which is regarded as clinically rele-
vant. SWB has been associated with longevity [26-28].
Chida and Steptoe showed in their meta-analysis that
high SWB was associated with reduced mortality in
healthy populations [29]. They also concluded that a
high SWB appeared to be protective against increased
mortality, even in CKD patients. We speculate that the
association between SWB and renal function could
provide a missing link between SWB, longevity, and
mortality [3,4,30] even in subjects without CKD.
SWB differs between the sexes [31,32] as also shown
in our cohorts. Therefore it is of special relevance that a
number of renal functions also differ between the sexes,
further supporting a link between renal function and
SWB. [33,34]. We contend that, based on the documented
links between renal function, SWB, and mortality, moni-
toring of cystatin C in the elderly may help identifying
subjects in need of more proactive treatment to prevent
further deterioration of renal function. Successful inter-
vention might impact both SWB and mortality positively
in the elderly. Prospective studies will be necessary to
address this possibility.
There are some limitations in our study. SWB is a
function of many variables such as socioeconomic status,
marital status, physical health, life expectations [35-37],
and in this study we were not able to control for all of
these factors. However, reverse causation (low PGWB
scores due to poor SES and/or marital status causing a
reduced GFR) seems unlikely as confounder, sinceestablishment of marital status and SES regularly take
place early in life whereas reduced GFR develops grad-
ually in the aging subject (Figure 1), and it thus appears
unlikely that a reduced GFR would significantly affect
marital status and SES. Personality and genetic variation
may also contribute substantially [38]. These factors
should be included in future studies.
Conclusion
Renal function even within the normal range, assessed
by serum cystatin C concentration, has significant and sex
specific associations with SWB and its subdimensions.
Maintenance of good renal function in aging may there-
fore be of importance not only in preventing somatic
deterioration in old age but also in maintaining a good
subjective well-being.
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